首页> 美国卫生研究院文献>other >Clinical Significance of Neutrophil Gelatinase-Associated Lipocalin in Crimean-Congo Hemorrhagic Fever
【2h】

Clinical Significance of Neutrophil Gelatinase-Associated Lipocalin in Crimean-Congo Hemorrhagic Fever

机译:中性粒细胞明胶酶相关的脂蛋白在克里米亚-刚果出血热中的临床意义

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Neutrophil gelatinase-associated lipocalin (NGAL), which is an important prognostic marker for sepsis and inflammatory diseases, is mostly released from neutrophils. Crimean-Congo hemorrhagic fever (CCHF) patients are generally neutropenic. We aimed to investigate whether there is a change in serum NGAL level and to investigate its effect on the recovery time (RT) during the course of CCHF. A total of 40 CCHF patients (19 females and 21 males) and 34 healthy controls (17 females and 17 males) were included in the study. The serum NGAL level and biochemical and hematological parameters were checked. The NGAL level of CCHF patients was significantly higher than that of the healthy controls (P < 0.001). A multivariate analysis showed that the independent prognostic factor for the prediction of the RT is the NGAL level (odds ratio [OR] 0.3, 95% confidence interval [Cl] 0.1–0.4, P < 0.001). An elevated NGAL level was found to be associated with an increased RT in CCHF patients. The NGAL levels of CHHF patients might be elevated due to increased cytokine release, the presence of a tissue injury, and the release of immature neutrophils from the bone marrow into the peripheral stream. This may be a good prognostic factor in CHHF patients.
机译:中性粒细胞明胶酶相关的脂蛋白(NGAL)是败血症和炎症性疾病的重要预后标志物,大部分从中性粒细胞中释放出来。克里米亚-刚果出血热(CCHF)患者通常是中性粒细胞减少的。我们的目的是调查CCHF过程中血清NGAL水平是否有变化,并研究其对恢复时间(RT)的影响。研究共纳入40例CCHF患者(19例女性和21例男性)和34例健康对照(17例女性和17例男性)。检查血清NGAL水平以及生化和血液学参数。 CCHF患者的NGAL水平显着高于健康对照组(P <0.001)。多元分析表明,预测RT的独立预后因素是NGAL水平(赔率[OR] 0.3,95%置信区间[Cl] 0.1-0.4,P <0.001)。发现NGAL水平升高与CCHF患者的RT升高有关。 CHHF患者的NGAL水平可能由于细胞因子释放增加,组织损伤的存在以及未成熟的中性粒细胞从骨髓释放到外周血中而升高。这可能是CHHF患者的良好预后因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号